Key facts
- This page summarizes Alan Boehme's Form 4 filing for Lovesac Co (LOVE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Jun 2026, 17:58.
Alan Boehme - 09 Jun 2026 Form 4 Insider Report for Lovesac Co (LOVE)
- Reporting relationship
- Director
- Issuer ticker
- LOVE
- Reported as of
- 09 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jun 2026, 17:58:26 UTC
- Prior SEC filing
- 11 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Megan C. Preneta, as Attorney-in-Fact for Alan Boehme
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alan Boehme filed Form 4 for Lovesac Co (LOVE) on 10 Jun 2026.
Change
- Previous filing in this sequence was filed on 11 Sep 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002084751
Primary reporting owner
Boehme Alan
- Relationship
- Director
- Address
- C/O THE LOVESAC COMPANY, 421 ATLANTIC STREET, SUITE 200, STAMFORD
- Signature
- /s/ Megan C. Preneta, as Attorney-in-Fact for Alan Boehme
- Signature date
- 10 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LOVE
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +7,947
- Change %
- Price
- $0.000000*
- Shares after
- 7,947
- Date
- 09 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,947
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
Footnote F2
The Reporting Person received a grant of RSUs of which 100% are subject to vesting on June 9, 2027.